Key result
Prophylactic administration of acenocoumarol in 1,134 surgical patients resulted in 0 fatal thrombo-embolic complications, 5 mild thrombo-embolic events, and 7 bleeding complications.
Why the study?
Does prophylactic acenocoumarol prevent fatal thrombo-embolic complications in surgical patients?
Observational (n=1,134)
Does prophylactic acenocoumarol prevent fatal thrombo-embolic complications in surgical patients?
Answers are grounded in this paper and cite their sources.
Prophylactic acenocoumarol in surgical patients effectively prevented fatal thrombo-embolic complications with a low incidence of bleeding.
To prevent fatal thrombo-embolic complications, 1134 surgical patients have received acenocoumarol (Sintrom) prophylactically. Our objective was achieved in this series: fatal complications did not occur, only 5 cases of mild thrombo-embolic complications were seen, with rapid recovery of all patients concerned. Bleeding, as a possible complication of anticoagulant administration, was seen in 7 cases.
No takes yet. Share an insight, caveat, or question.
Pieter A. Klok (1973) conducted an observational in Surgical patients at risk of thrombo-embolic complications (n=1,134). Acenocoumarol (Sintrom) was evaluated on Fatal thrombo-embolic complications. Prophylactic administration of acenocoumarol in 1,134 surgical patients resulted in 0 fatal thrombo-embolic complications, 5 mild thrombo-embolic events, and 7 bleeding complications.
Synapse has enriched 10 related papers. Consider them for comparative context: